You are here

Novartis

Novartis bribery investigation craters after Greek prosecutors clear 4 officials

Fierce Pharma

Tue, 04/9/19 - 06:52 pm

It’s a seller’s world in biotech M&A, and Novartis CEO Vas Narasimhan has his check book out and pen ready

Endpoints

Tue, 04/9/19 - 08:31 am

Novartis completes spin-out of Alcon eye unit

Pharmaforum

Tue, 04/9/19 - 08:21 am

Scotland backs Aimovig for migraine after NICE says no

Pharmaforum

Tue, 04/9/19 - 08:20 am

The top 15 pharma companies by 2018 revenue

Fierce Pharma

Mon, 04/8/19 - 11:30 pm

Bristol-Myers Squibb

Gilead Sciences

Teva Pharmaceutical

Lawsuit over migraine deal could be good for Amgen, analysts say

Marketwatch

Sat, 04/6/19 - 02:09 pm

Amgen and Novartis file dueling lawsuits over their deal to market a migraine drug

Stat

Thu, 04/4/19 - 11:22 pm

Novartis sues Amgen over migraine treatment Aimovig

Yahoo/Reuters

Thu, 04/4/19 - 12:04 pm

Novartis CEO's $50 Billion of Deals Was Just the First Act

Yahoo/Bloomberg

Thu, 04/4/19 - 12:01 pm

Novartis' SMA gene therapy would not be cost-effective if priced over $1.5M: ICER

Fierce Pharma

Thu, 04/4/19 - 11:54 am

spinal muscular atrophy

Sandoz resubmission puts Amgen's Neulasta at further risk of competition

Biopharma Dive

Wed, 04/3/19 - 09:31 pm

Another day, another $100M-plus biotech megaround as radiopharmaceuticals’ popularity grows

Endpoints

Tue, 04/2/19 - 12:20 pm

Fusion Pharmaceuticals

radiopharmaceuticals

Novartis' AveXis buys AstraZeneca site in Colorado as it anticipates gene therapy launch

Fierce Pharma

Tue, 04/2/19 - 11:54 am

drug manufacturing

Did Novartis hand out kickbacks or host educational dinners? A jury may decide

Fierce Pharma

Mon, 04/1/19 - 10:58 pm

physician payments

Novartis Adds Inflammation Drugs to Pipeline with Deal for IFM Tre

Xconomy

Mon, 04/1/19 - 10:31 am

anti-inflammatory

2 Blockbuster Gene Therapy Programs to Watch in 2019

Motley Fool

Sun, 03/31/19 - 03:42 pm

3 Leading Alzheimer's Disease Drugs in Development After Biogen's Aducanumab Flop

Motley Fool

Sat, 03/30/19 - 12:44 pm

Alzheimer's disease

Axsome Therapeutics

FDA approves Novartis' Mayzent for MS

BioCentury

Tue, 03/26/19 - 11:02 pm

relapsing multiple sclerosis

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Yahoo/Benzinga

Sun, 03/24/19 - 12:02 pm

Eiger BioPharmaceuticals

Proteostasis Therapeutics

Fibrocell Science

Supernus Pharmaceuticals

INSYS Therapeutics

Novartis launches COPD inhalers in China

Drug Delivery Business News

Fri, 03/22/19 - 11:54 am

Ultibro Breezhaler

Seebri Breezhaler

Pages